Hoba Therapeutics

About:

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Website: https://hobatherapeutics.com

Top Investors: European Innovation Council, EIC Accelerator, Novo Holdings, Export and Investment Fund, Indaco Venture Partners

Description:

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Total Funding Amount:

$29.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2016-01-01

Founders:

Kenneth Ahrend Petersen

Number of Employees:

1-10

Last Funding Date:

2023-12-10

IPO Status:

Private

Industries: